Trial intelligence / Profile preview

Efficacy of Oral Serratiopaptidase Vs Dexamethasone on Post-Operative Inflammation After Exodontia

NCT07785596Completed

Sponsor
Kharadar General Hospital
Start
Jan 2025
Primary completion
Jan 2025
Countries
1
01

Overview

Trial of serrapeptase in post-operative inflammation, postoperative edema and postoperative pain (2 arms), sponsored by Kharadar General Hospital. Primary endpoint: Post-operative facial swelling at 72 hours. Started Jan 2025; status: completed.

02

Drugs

serrapeptase
03

Conditions

post-operative inflammationpostoperative edemapostoperative pain

Beyond the preview

Go deeper on NCT07785596.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07785596.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call